Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aston University and pharmaceutical giant sign for medical future of Midlands

11.10.2004


Aston University in Birmingham, UK has just signed a long-term agreement with pharmaceutical manufacturing giant, Mayne Pharma Plc , to run the first dedicated medical manufacturing clean room in the region.



The room will be used to produce specialist cancer and other drugs and make them available across the Midlands. This will address the particular need in the region for aseptic facilities to support the preparation of pharmaceuticals with a short shelf life - particularly in the treatment of children. In addition to this, the agreement - which was facilitated by Aston University’s Business Partnership Unit – will also create a unique opportunity for the West Midlands.

Guppy Dhariwal, Director of Finance and Business Services at Aston stated: “Aston University is delighted to be entering into this exciting new partnership. It will not only create new jobs in the region but it will, to the best of our knowledge, be the first manufacturing unit of its type that brings together high-quality university research with advanced pharmaceutical manufacturing techniques.”


The alliance will offer Aston University (which boasts the only pharmacy school in the region) and Mayne Pharma numerous collaborative opportunities, and will contribute directly to the University’s research and teaching in pharmacy.

John Edwards Chief Executive of Advantage West Midlands said: “Medical technologies is a growth industry in this region and we’re delighted to support Aston University in this exciting venture.”

The clean room provides an ultra clean, sterile and controlled environment for pharmaceutical manufacture, research and teaching and will offer a complete specialist environment to support the development of new medicines. Its rooms are temperature and humidity controlled to allow the aseptic production, manipulation and reconstitution of a variety of medical products (including chemotherapy drugs usually used in the treatment of cancer and individually tailored treatments for premature babies) that cannot be sterilised commercially.

Scott Richards, President, Mayne Pharma EMEA, said: “This is an important development for growing Mayne’s aseptic manufacturing business operations in the UK. Being located at such a research-focussed university as Aston in Birmingham, and so close to excellent transport links will enable us to offer outstanding levels of service for our customers in the Midlands whilst also supporting our wider UK business.”

Paul Burkwood | alfa
Further information:
http://www.aston.ac.uk

More articles from Life Sciences:

nachricht Nonstop Tranport of Cargo in Nanomachines
20.11.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik

nachricht Researchers find social cultures in chimpanzees
20.11.2018 | Universität Leipzig

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Nonstop Tranport of Cargo in Nanomachines

20.11.2018 | Life Sciences

Researchers find social cultures in chimpanzees

20.11.2018 | Life Sciences

When AI and optoelectronics meet: Researchers take control of light properties

20.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>